BioRestorative Therapies, Inc.

2.07 USD
+0.04 (+1.97%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

BioRestorative Therapies, Inc. stock is up 60.47% since 30 days ago. The next earnings date is Aug 9, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 21.74% of the previous 26 June’s closed higher than May. 100% of analysts rate it a buy.

About BioRestorative Therapies, Inc.

The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies in August 2011.